Endocan serum concentration in uninfected newborn infants

Introduction: Endocan is a specific endothelial mediator involved in the inflammatory response. Its role in the diagnosis of sepsis has been studied in adult patients and late onset neonatal sepsis. The clinical signs of early onset sepsis (EOS) are nonspecific and routinely used biomarkers, such a...

Full description

Saved in:
Bibliographic Details
Main Authors: Gabriela I Zonda, Radu Zonda, Andrei T Cernomaz, Luminita Paduraru, Bogdan D Grigoriu
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2019-09-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/11660
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850193180075491328
author Gabriela I Zonda
Radu Zonda
Andrei T Cernomaz
Luminita Paduraru
Bogdan D Grigoriu
author_facet Gabriela I Zonda
Radu Zonda
Andrei T Cernomaz
Luminita Paduraru
Bogdan D Grigoriu
author_sort Gabriela I Zonda
collection DOAJ
description Introduction: Endocan is a specific endothelial mediator involved in the inflammatory response. Its role in the diagnosis of sepsis has been studied in adult patients and late onset neonatal sepsis. The clinical signs of early onset sepsis (EOS) are nonspecific and routinely used biomarkers, such as C-reactive protein and procalcitonin, have low sensitivity, specificity and positive predictive value. Endocan could be useful as a biomarker for diagnosis of EOS, but at present normal range values for this molecule have not been reported. The aim of this study is to establish the normal values range for serum endocan in term and preterm newborns without risk factors for EOS and to characterize the variation pattern of its levels at different postnatal moments. Methodology: Mean endocan serum concentration (ESC) was measured in term and preterm newborns without clinical suspicion of EOS at different moments from birth. Results: ESC (ng/mL) in term newborns was 1.74+/-0.13 on day 1 and 2.02+/-0.41 on day 3 respectively, (p=0.09). In preterm newborns ESC (ng/mL) was 2.02+/-0.11 and 1.97+/-0.18, (p=0.8) for day 1 and 3 respectively. ESC was not significantly influenced by sex, mode of delivery, evidence of fetal distress or presence of minor birth trauma. Conclusions: ESC (ng/mL) between the first and third day of life in either term or preterm infants don’t appear to be significantly influenced by factors that are associated with elevation of inflammatory markers, thus using this biomarker for the diagnosis of EOS might reduce the false positive results.
format Article
id doaj-art-0e3738f89b954d09a611012a9bcdb11a
institution OA Journals
issn 1972-2680
language English
publishDate 2019-09-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-0e3738f89b954d09a611012a9bcdb11a2025-08-20T02:14:20ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802019-09-01130910.3855/jidc.11660Endocan serum concentration in uninfected newborn infantsGabriela I Zonda0Radu Zonda1Andrei T Cernomaz2Luminita Paduraru3Bogdan D Grigoriu4Division of Neonatology, Department of Mother and Child Care, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania"PetruPoni" Institute of Macromolecular Chemistry, Iași, RomaniaDivision of Pneumology, Department of Medical Specialties III, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, RomaniaDivision of Neonatology, Department of Mother and Child Care, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, RomaniaDivision of Pneumology, Department of Medical Specialties III, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania Introduction: Endocan is a specific endothelial mediator involved in the inflammatory response. Its role in the diagnosis of sepsis has been studied in adult patients and late onset neonatal sepsis. The clinical signs of early onset sepsis (EOS) are nonspecific and routinely used biomarkers, such as C-reactive protein and procalcitonin, have low sensitivity, specificity and positive predictive value. Endocan could be useful as a biomarker for diagnosis of EOS, but at present normal range values for this molecule have not been reported. The aim of this study is to establish the normal values range for serum endocan in term and preterm newborns without risk factors for EOS and to characterize the variation pattern of its levels at different postnatal moments. Methodology: Mean endocan serum concentration (ESC) was measured in term and preterm newborns without clinical suspicion of EOS at different moments from birth. Results: ESC (ng/mL) in term newborns was 1.74+/-0.13 on day 1 and 2.02+/-0.41 on day 3 respectively, (p=0.09). In preterm newborns ESC (ng/mL) was 2.02+/-0.11 and 1.97+/-0.18, (p=0.8) for day 1 and 3 respectively. ESC was not significantly influenced by sex, mode of delivery, evidence of fetal distress or presence of minor birth trauma. Conclusions: ESC (ng/mL) between the first and third day of life in either term or preterm infants don’t appear to be significantly influenced by factors that are associated with elevation of inflammatory markers, thus using this biomarker for the diagnosis of EOS might reduce the false positive results. https://jidc.org/index.php/journal/article/view/11660newbornearly onset sepsisendocanbiomarkerendothelium
spellingShingle Gabriela I Zonda
Radu Zonda
Andrei T Cernomaz
Luminita Paduraru
Bogdan D Grigoriu
Endocan serum concentration in uninfected newborn infants
Journal of Infection in Developing Countries
newborn
early onset sepsis
endocan
biomarker
endothelium
title Endocan serum concentration in uninfected newborn infants
title_full Endocan serum concentration in uninfected newborn infants
title_fullStr Endocan serum concentration in uninfected newborn infants
title_full_unstemmed Endocan serum concentration in uninfected newborn infants
title_short Endocan serum concentration in uninfected newborn infants
title_sort endocan serum concentration in uninfected newborn infants
topic newborn
early onset sepsis
endocan
biomarker
endothelium
url https://jidc.org/index.php/journal/article/view/11660
work_keys_str_mv AT gabrielaizonda endocanserumconcentrationinuninfectednewborninfants
AT raduzonda endocanserumconcentrationinuninfectednewborninfants
AT andreitcernomaz endocanserumconcentrationinuninfectednewborninfants
AT luminitapaduraru endocanserumconcentrationinuninfectednewborninfants
AT bogdandgrigoriu endocanserumconcentrationinuninfectednewborninfants